Virtual Shareholders Meeting

Virtual Shareholders Meeting

On 20 April 2020, AVITA Medical announced its intention to redomicile AVITA Medical and its subsidiaries (Avita Group) from Australia to the United States of America by way of a scheme of arrangement under which AVITA Therapeutics, Inc., a newly-formed company incorporated in Delaware in the United States of America, will become the parent company of the Avita Group (Scheme).

On 11 May 2020, the Federal Court of Australia approved orders to convene a general meeting of AVITA Medical’s shareholders at 9:00am (AEST) on Monday, 15 June 2020 for the purpose of considering a resolution to approve the Scheme (Scheme Meeting).

In light of the restrictions imposed by Australian governments in response to COVID-19, the Scheme Meeting will be conducted exclusively as a virtual meeting by way of a live webcast. Taking part in the live webcast will enable shareholders to listen to the Scheme Meeting live, view slides and proxy results and to also ask questions and cast their vote at the appropriate times whilst the Scheme Meeting is in progress.

Shareholders who are registered as at 9:00am (AEST) on Saturday, 13 June 2020 in AVITA Medical’s share register will be entitled to vote at the live webcast of the Scheme Meeting. Shareholders can access the live webcast by following the instructions below.

Shareholders are invited to participate in the Scheme Meeting by way of the live webcast on two available platforms


Visit on your smartphone, tablet or computer. You will need the latest versions of Chrome, Safari, Internet Explorer 11, Edge or Firefox. Please ensure your browser is compatible.


Download the Lumi AGM app from the Apple App Store or Google Play Stores by searching for “Lumi AGM”.

Log-in details for shareholders and guests

Once you have accessed the Lumi platform on your web browser or mobile app, you will be prompted to enter the meeting ID number.

MEETING ID: 316-817-384

Online registration will open one hour prior to the start of the Scheme Meeting. To login, you must have the following information:


Username: SRN / HIN

Password: Postcode of registered holding


Username: SRN / HIN

Password: Three letter country code (for example, United States of America: “USA”)

A full list of country codes is provided in the Scheme Meeting User Guide (provided below).


You will be asked to enter your name and email address.

Guests will not be able to ask questions or vote at the Scheme Meeting by way of the live webcast.

Voting Instructions

The resolution to approve the Scheme will be decided on a poll and shareholders can vote by participating in the live webcast or by appointing a proxy by:

  • Completing and signing the proxy form mailed to you with the Scheme Booklet (for those shareholders who have opted to receive notices by mail) and returning it in accordance with the instructions set out on the proxy form; or
  • Completing a proxy form online through InvestorVote ( You will need your SRN or HIN and the Control number: 183787.

Completed proxy forms (or proxy appointments submitted online through InvestorVote) must be received by AVITA Medical’s share registry by no later than 9:00am (AEST) on Saturday, 13 June 2020.

Section 3 of the Scheme Booklet (provided below) entitled ‘Voting on the Proposed Transaction’ provides further information on voting at the Scheme Meeting, including how to vote by way of live webcast or by proxy, attorney or corporate representative, and on the voting process for shareholders who hold shares in AVITA Medical represented by American Depositary Shares (ADSs).

Additional information regarding participating in the live webcast of the Scheme Meeting is detailed in the Scheme Meeting User Guide (provided below).

Q&A Session

Shareholders are invited to lodge questions in advance of the Scheme Meeting by sending an email containing your question(s) to by 5:00pm (AEST) on Monday, 8 June 2020. Emailed questions will be addressed during the Scheme Meeting.

The live webcast will also include a facility for shareholders to submit questions during the Scheme Meeting, however please note:

  • Shareholders can only submit their questions online once they have been verified;
  • Questions can be submitted any time during the live webcast until the Chair closes the Question and Answer session; and
  • Shareholders are encouraged to lodge their questions prior to the Scheme Meeting to the email address above.

Navigating through the web browser or app

  • Once logged in, you will see the homepage, which displays the Scheme Meeting information and documents and various icons.
  • To view the webcast, you must tap the broadcast bar Broadcast Bar on your screen. If prompted, you may have to click the play button in the window to initiate the broadcast. Video and/or slides of the Scheme Meeting will appear after approx. 30 seconds dependent on the speed of your internet. Toggle between the up or down arrow to view another screen.
  • To ask questions, tap on the question’s icon Questions Iconto submit a question, type your question in the chat box at the bottom of the screen and then select the send icon. Confirmation that your message has been received will appear.
  • To view the Scheme Meeting information on the homepage, click on the homepage icon Homepage Icon.
This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our privacy policy.